Indianapolis, IN, United States of America

Francisco Alcides Valenzuela

This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francisco Alcides Valenzuela. Retrieved from https://idiyas.com/inventor/francisco-alcides-valenzuela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Francisco Alcides Valenzuela: Innovating Diabetes Treatment

Introduction

Francisco Alcides Valenzuela is an accomplished inventor based in Indianapolis, Indiana, known for his significant contributions to diabetes treatment through his innovative work at Eli Lilly and Company. With a total of three patents to his name, Valenzuela has been instrumental in advancing medical solutions that aim to improve the lives of individuals affected by diabetes and hyperglycemia.

Latest Patents

Valenzuela's latest inventions include a series of acylated insulin compounds that provide new pathways for managing blood glucose levels. These compounds are designed specifically for the treatment of diabetes and hyperglycemia. The pharmaceutical compositions associated with these innovations not only contribute to lowering blood glucose but also encompass various therapeutic uses and an intermediate compound utilized in the synthesis of the acylated insulin compounds.

Career Highlights

At Eli Lilly and Company, Valenzuela plays a critical role in the research and development of cutting-edge pharmaceutical products. His work focuses on creating more effective treatments for diabetes, reflecting his commitment to advancing healthcare and addressing significant medical challenges. With his expertise and innovative approach, Valenzuela continues to make valuable contributions to the field of medicine.

Collaborations

Throughout his career, Valenzuela has collaborated with esteemed colleagues, including Adam Robert Mezo and Wen Liu. Together, they have fostered an environment of innovation and creativity, pushing the boundaries of what is possible in diabetes treatment and management.

Conclusion

Francisco Alcides Valenzuela exemplifies the spirit of invention and innovation in the field of medicine. His work not only represents a personal achievement but also serves as a beacon of hope for millions living with diabetes. As he continues to develop groundbreaking therapies, Valenzuela stands out as a vital contributor to the ongoing fight against diabetes and its associated challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…